Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients.
about
A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinomaRe-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreasNew challenges in perioperative management of pancreatic cancerPreoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.A Bayesian model for misclassified binary outcomes and correlated survival data with applications to breast cancer.Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor.A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients.Outcomes and prognostic factors of patients with stage IB and IIA pancreatic cancer according to the 8th edition American Joint Committee on Cancer criteria.Strong prognostic value of nodal and bone marrow micro-involvement in patients with pancreatic ductal carcinoma receiving no adjuvant chemotherapy.Impact of tumor grade on prognosis in pancreatic cancer: should we include grade in AJCC staging?McGill Brisbane Symptom Score for patients with resectable pancreatic head adenocarcinomaThe role of surgery for pancreatic cancer: a 12-year review of patient outcome.Unresectable pancreatic adenocarcinoma: do we know who survives?Pancreatic carcinoma: palliative surgical and endoscopic treatment.Detection of CK20mRNA in peripheral blood of pancreatic cancer and its clinical significanceMultiple treatment cycles of liposome-encapsulated adenoviral RIP-TK gene therapy effectively ablate human pancreatic cancer cells in SCID mice.The incidence and survival rate of population-based pancreatic cancer patients: Shanghai Cancer Registry 2004-2009.Surgical treatment of the pancreatic stump: preventive strategies of pancreatic fistula after pancreatoduodenectomy for cancer.Comparison of 1-, 2-, and 3-Dimensional Tumor Response Assessment After Neoadjuvant GTX-RT in Borderline-Resectable Pancreatic Cancer.Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer.The Clinical and Pathological Significance of Nectin-2 and DDX3 Expression in Pancreatic Ductal Adenocarcinomas.Results of vascular resections during pancreatectomy from two European centres: an analysis of survival and disease-free survival explicative factors.Palliation With Endoscopic Metal Stents May Be Preferable to Surgical Intervention for Patients With Obstructive Pancreatic Head AdenocarcinomaThe Role of Neoadjuvant Chemoradiation Therapy in Patients With Borderline Resectable Pancreatic Cancer With Isolated Venous Vascular InvolvementSurgical treatment of liver metastases from pancreatic cancer.Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands.Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinomaPerioperative transfusion for pancreaticoduodenectomy and its impact on prognosis in resected pancreatic ductal adenocarcinoma.Shen's Whole-Layer Tightly Appressed Anastomosis Technique for Duct-to-Mucosa Pancreaticojejunostomy in Pancreaticoduodenectomy.Re-evaluating the impact of tumor size on survival following pancreaticoduodenectomy for pancreatic adenocarcinoma.Factors influencing survival in patients undergoing palliative bypass for pancreatic adenocarcinoma.Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial.Impact of cardiac comorbidity on early outcomes after pancreatic resection.Dramatic Survival Benefit Related to R0 Resection of Pancreatic Adenocarcinoma in Patients With Tumor ≤25 mm in Size and ≤1 Involved Lymph NodesLong-term survival in patients with pancreatic ductal adenocarcinoma.Modelling prognostic factors in advanced pancreatic cancerValidation of a prognostic nomogram in patients undergoing resection for pancreatic ductal adenocarcinoma in a UK tertiary referral centre.Resection margins and R1 rates in pancreatic cancer--are we there yet?Preoperative platelet count and survival prognosis in resected pancreatic ductal adenocarcinomaCurrent surgical aspects of palliative treatment for unresectable pancreatic cancer.
P2860
Q26748880-2F4B8739-8BE2-45C8-8803-1B79D84D348CQ28075892-E46168E7-A52E-452F-BDB3-82FC80A120ADQ28082422-8EF09155-AF0C-4B0F-84CD-F977169C00A9Q30452636-65CF1BB1-EDF1-4168-B2B3-BAE30B8BE4F0Q30569255-41AB3A8A-0ADD-4BAE-ADEF-FDF9823EA9F0Q33314616-7AEFBB59-FA05-4FFA-87D0-64E94D6371A0Q33439342-DED8F189-8171-4D1A-8C33-CAB341868CB4Q33599558-032E02FA-94F5-4AE6-86F4-FFDEE496B31BQ33909694-7BFCCA73-F747-4D76-8BDF-9AEBB755FDC5Q34075815-E4CB3A54-9B30-40C5-91AC-D3396B5E1194Q34168562-71F1A2BE-AA80-4786-AC1A-0A58C1A3B13FQ34357302-2C54AB59-84EF-4AE1-8580-DB7887B7A4E6Q34383327-C6185191-0FE6-4FAF-A24A-F2AA5CDACB84Q34589299-3E0E71D1-69E6-4E90-86C2-482EADD31CCEQ34605528-45B02C29-418F-4D82-995E-56790BD86283Q34768940-2AA35B34-02F8-4C1D-9435-A86A5E09D3CFQ35018453-C7A3BF82-137F-4E12-B5CE-87DC4F4F4460Q35063265-1A7B8A77-4661-44F3-9ACF-BD42022FE544Q35768026-CCE3CA07-6432-4DCB-A753-880A6436333FQ35892368-DAA6AF16-E1D5-4D56-AD46-5BDDAD56757CQ35947249-3D0F5FF8-DC0C-4CF6-A328-425A90A3D659Q36063404-57D9E50F-799B-497C-9FC6-835961BA007CQ36104305-99C5689A-B1CF-4BC0-A0FB-97C88294D609Q36194657-1241D62E-8376-401D-B7DA-F01875210485Q36253223-2E943153-B8F6-4B23-A0EF-5B281B612612Q36331142-16777916-8B7D-4DE1-A3F0-13CBBFE332C2Q36408348-C761FF7F-EC6F-4D64-A75F-8CBF48BFB043Q36408362-3438998A-7D6D-42AD-8129-4705C17270BAQ36603548-7547A781-CE16-470D-A6AC-FDABAB59B4FFQ36626551-D5B8EECE-B110-4A96-B906-EBC03A5AA96BQ36626566-0FE9A9F8-7AF2-43FF-84AE-567EFDA3A1BBQ36668274-FD57AC04-7AE4-4E28-BCC4-3C75B18DE506Q36720889-AEE15F6E-15FF-4FB4-9DD2-03EFA986AC48Q36737989-7FFEF844-D164-4399-8EEE-313599D35E99Q36869288-35CDF287-61E1-4A44-9DEB-88CD359D3804Q36882688-9710B07B-5E75-4909-8481-BF68E15AE4F1Q37002603-CB61042F-6D64-4325-B97D-E66B291D1DC5Q37032854-DDAE3A16-78B4-4F92-A4D1-D99051A9E5B5Q37068809-5FE107E6-4D23-4360-AE92-510ECA467BB1Q37129811-E17923D6-C2BA-4F23-9A39-814826DCE330
P2860
Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Surgical treatment of pancreat ...... ostic factors in 343 patients.
@en
Surgical treatment of pancreat ...... ostic factors in 343 patients.
@nl
type
label
Surgical treatment of pancreat ...... ostic factors in 343 patients.
@en
Surgical treatment of pancreat ...... ostic factors in 343 patients.
@nl
prefLabel
Surgical treatment of pancreat ...... ostic factors in 343 patients.
@en
Surgical treatment of pancreat ...... ostic factors in 343 patients.
@nl
P2093
P1476
Surgical treatment of pancreat ...... ostic factors in 343 patients.
@en
P2093
Kuhlmann KF
Offerhaus GJ
Wesseling JG
de Castro SM
ten Kate FJ
van Gulik TM
P304
P356
10.1016/J.EJCA.2003.10.026
P577
2004-03-01T00:00:00Z